Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$100.3K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Jun 11 | BCRX | Biocryst Pharmaceuticals… | AGRANT | 15,294 | — | — | +48.0% | Open the original filing on SEC.gov |
| May 29 | BCRX | Biocryst Pharmaceuticals… | AGRANT | 631 | $8.91 | $5.6K | +2.0% | Open the original filing on SEC.gov |
| May 18 | BCRX | Biocryst Pharmaceuticals… | SSELL | 11,180 | $8.97 | $100.3K | -26.4% | Open the original filing on SEC.gov |
| Feb 27 | BCRX | Biocryst Pharmaceuticals… | AGRANT | 642 | $8.75 | $5.6K | +1.5% | Open the original filing on SEC.gov |
| Nov 28, 2025 | BCRX | Biocryst Pharmaceuticals… | AGRANT | 783 | $7.18 | $5.6K | +1.9% | Open the original filing on SEC.gov |
| Aug 29, 2025 | BCRX | Biocryst Pharmaceuticals… | AGRANT | 676 | $8.31 | $5.6K | +1.7% | Open the original filing on SEC.gov |
| Jun 12, 2025 | BCRX | Biocryst Pharmaceuticals… | AGRANT◆ | 27,181 | — | — | — | Open the original filing on SEC.gov |
| Jun 12, 2025 | BCRX | Biocryst Pharmaceuticals… | AGRANT | 12,500 | — | — | +44.9% | Open the original filing on SEC.gov |